Research programme: nitric oxide donors - Lacer

Drug Profile

Research programme: nitric oxide donors - Lacer

Alternative Names: LA-8045

Latest Information Update: 21 Sep 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lacer
  • Class Nitroso compounds; S-nitrosothiols
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Acute coronary syndromes; Stroke

Most Recent Events

  • 21 Sep 2010 Preclinical development is ongoing in Spain
  • 21 Sep 2010 Research programme: nitric oxide donors - Lacer is available for licensing as of 04 Apr 2006. http://www.lacer.es
  • 05 Sep 2007 This compound is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top